A top U.S. Department of Justice lawyer today pitched forging a greater bond between the government and the pharmaceutical industry to better combat health care fraud.

In remarks at the CBI Pharmaceutical Compliance Congress, Stuart Delery, the assistant attorney general for the Civil Division, touted the importance of an “ethical corporate culture,” corporate compliance as a key business strategy, and transparency in fraud cases.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]